|
|
|
|
NORMALIZATION OF LIVER-RELATED LABORATORY PARAMETERS IN HCV GENOTYPE 1-INFECTED PATIENTS WITH CIRRHOSIS AFTER TREATMENT WITH ABT-450/R/OMBITASVIR, DASABUVIR AND RIBAVIRIN
|
|
|
Reported by Jules Levin
ACG Annual Scientific Meeting
Philadelphia, PA, October 20, 2014
Gregory Everson, Samuel Lee, Stefan Zeuzem, Pietro Andreone, Stanislas Pol, Marc Bourliere, Angeles Castro, Marina Berenguer, Sandra Lovell, Marcos Pedrosa, Roger Trinh
|
|
|
|
|
|
|